Positron Emission Tomography–Computed Tomography (PET/CT) Fusion Practice Exam

PET/CT imaging is particularly valuable in oncology for evaluating metabolic activity in cancerous tissues, and one of the primary focuses of this imaging modality is the lungs. Lung cancer is one of the most common types of cancer, and the detection and staging of lung tumors are crucial for treatment planning. PET scans help to identify areas of increased metabolic activity that may indicate the presence of malignancy, which is essential for guiding further interventions.

The utilization of PET/CT in the lungs allows for not only the detection of primary lung tumors but also the assessment of metastatic disease. The ability to combine metabolic information from the PET component with high-resolution anatomical details from the CT allows for a comprehensive evaluation of lung pathology, aiding in accurate diagnosis and management.

While other organs such as the heart, liver, and brain may also be assessed with PET/CT imaging, the focus on the lungs in the context of cancer care is particularly pronounced due to the high prevalence and critical implications of lung cancer. Thus, the emphasis on lung imaging reflects the greater clinical significance and the need for precise evaluation in cases of suspected malignancy.